Skip to main content
Clinical Trials/NL-OMON20697
NL-OMON20697
Recruiting
Not Applicable

The value of nerve ultrasound in patients with neurofibromatosis type 1

Erasmus MC0 sites60 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
eurofibromotosis type 1
Sponsor
Erasmus MC
Enrollment
60
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Erasmus MC

Eligibility Criteria

Inclusion Criteria

  • Age \=18 years
  • \-Diagnosed with NF1 (see below for diagnostic criteria)
  • \-Treatment at the outpatient clinic of the Erasmus MC Cancer Institute (Rotterdam)
  • Criteria for diagnosis NF1:
  • Two or more of the following clinical features are sufficient to establish a diagnosis of neu\-rofibromatosis type 1:
  • Six or more cafe\-au\-lait macules (\>0,5 cm at largest diameter in a prepubertal child or \>1,5 cm in post\-pubertal individuals)
  • Axillary freckling or freckling in inguinal regions
  • Two or more neurofibromas of any type or one or more plexiform neurofibromas
  • Two or more Lisch nodules (iris hamartomas)
  • A distinctive osseous lesion (sphenoid wing dysplasia, long\-bone dysplasia)

Exclusion Criteria

  • \-comorbidity associated with (poly)neuropathy (e.g. alcoholism, diabetes mellitus)
  • \-comorbidity mimicking neuropathic complaints (e.g. myelopathy)
  • \-inability to give informed consent or to undergo HRUS

Outcomes

Primary Outcomes

Not specified

Similar Trials